Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021

SELL
$16.86 - $19.67 $181,379 - $211,609
-10,758 Closed
0 $0
Q3 2020

Oct 14, 2020

SELL
$15.4 - $20.16 $585 - $766
-38 Reduced 0.35%
10,758 $186,000
Q2 2020

Aug 04, 2020

BUY
$18.24 - $21.45 $196,919 - $231,574
10,796 New
10,796 $198,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Btc Capital Management, Inc. Portfolio

Follow Btc Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btc Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Btc Capital Management, Inc. with notifications on news.